Biofabricating the future
Engineering Human
Tissue
Transforming Medicine
We bioprint nasal cartilage to accelerate drug development and advance regenerative solutions for facial reconstruction.
We bioprint nasal cartilage to accelerate drug development and advance regenerative solutions for facial reconstruction.
NovusTex is developing a reproducibility-driven bioengineering platform that enables intranasal therapeutic development today and supports future craniofacial reconstruction.
✔ Intranasal toxicity testing
✔ Formulation optimization
✔ Drug absorption & diffusion studies
✔ Local tissue interaction analysis
✔ Translational preclinical screening
✔ Biomaterial design & selection
✔ Cell-based tissue engineering
✔ Controlled tissue architecture
✔ Standardized fabrication workflows
✔ Iterative testing & optimization
Building a Scalable Regenerative Bioengineering Platform
Built by a team bridging medicine and engineering to translate complex biology into scalable, high-impact therapeutic platforms
Co-Founder & CEO
Leading NovusTex with a vision to transform how engineered tissues are designed and translated into real-world applications
Co-Founder & CTO
As CTO, he builds the scientific foundation enabling NovusTex’s platform for therapeutic development and regenerative applications
Traditional in vitro models fail to capture the complexity and predictability of human nasal tissue.
NovusTex enables a transition to reproducible, high-fidelity engineered tissue systems designed for translational accuracy.
